64; p<0001), platelet count <150×103/μL (HR: 769; p<0001), age

64; p<0.001), platelet count <150x103/μL (HR: 7.69; p<0.001), age >60 years (HR: 4.28; p<0.001),

diabetes (HR: 3.96; p<0.001), serum AST level >40 IU/L (HR: 3.79; p<0.001), and serum albumin level <4.0 g/dL (HR: 2.56; P=0.008) as independent risk factors for HCC. Regarding the FIB4-index, 130 NAFLD NVP-BGJ398 supplier patients (1.96%) and 24 (2.54%) AFLD patients were considered to have advanced fibrosis (presence of bridging fibrosis equivalent to NASH stage 3-4), and these estimated advanced fibrotic patients had a significantly higher incidence of HCC than estimated non-advanced fibrotic patients in each group. Conclusions: Excessive alcohol consumption has a considerable effect on hepatocarcinogenesis in fatty liver disease compared with NAFLD. And, non-invasive predictive procedures of liver fibrosis the FIB4-index possibly useful for prediction of high risk group of HCC in fatty liver patients with or without excessive alcohol consumption. http://www.selleckchem.com/products/Rapamycin.html Disclosures: Kenji Ikeda – Speaking and Teaching: Dainippon Sumitomo Pharmaceutical Company Norio Akuta – Patent Held/Filed: SRL. Inc. Hiromitsu Kumada – Speaking and Teaching: Bristol-Myers Squibb,Pharma International The following people have nothing to disclose: Yusuke Kawamura, Yasuji Arase, Taito Fukushima, Tasuku Hara, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Hitomi

Sezaki, Fumitaka Suzuki, Yoshiyuki Suzuki, Yuki Ohmoto, Kazuhisa Amakawa, Hiroshi Tsuji Introduction) Smoking increases the risk of cardiovascular diseases and lung cancer. However, the effect selleck inhibitor of smoking on progression and carcinogenesis in liver diseases such as nonalcoholic fatty liver disease (NAFLD) and alcoholic liver diseases (ALD) has not been clear. In this study, we investigated the relationship between smoking and the clinical features in NAFLD, the rates of hepatocellular carcinoma (HCC) and extra-hepatic

malignancies. Patients and Methods) 1) Three hundred forty-six NAFLD patients who underwent liver biopsy were divided into three groups: a non-smoking group (212 patients; mean age 52, male 63%), a past-smoking group (65 patients; mean age 54, male 66%) and a present-smoking group (69 patients; mean age 52, male 65%). Among the three groups, lifestyle-related diseases prevalence, blood test results and liver histological findings were compared. 2) Seventy-two patients with NAFLD liver cirrhosis (NAFLD-LC) and 85 patients with ALD liver cirrhosis (ALD-LC) were enrolled. The occurrence rate of HCC and extrahepatic malignancies were investigated. Results)1. Age and gender were almost the same among the three groups of NAFLD. Serum liver function test results (albumin, total bilirubin, AST, ALT, g-GTP, Platelet counts, prothrom-bin time) were not significantly different. However, HbA1C in the present-smoking groups was significantly higher (mean HbA1C<%>: present-smoking 6.6; past-smoking 5.9; nonsmoking 5.9).

Comments are closed.